Category Archives: Internal Medicine

Internal Medicine

Another Medical Society Turns Up the Heat on MOC – Medpage Today

The Infectious Diseases Society of America (IDSA) urged the American Board of Internal Medicine (ABIM) to make substantial changes to its maintenance of certification (MOC) requirements in a letter published Thursday.

"We assert the current ABIM MOC program is not a good metric for measuring ongoing competence in the field, and it should be reexamined and modified to meet the current demands of the workforce," IDSA president Steven Schmitt, MD, of the Cleveland Clinic, wrote in the letter to ABIM President and CEO Richard Baron, MD.

"We strongly request that corrective action be taken and substantive changes be made to the program that address the important concerns of the ID community," Schmitt wrote in the letter, which was published in Clinical Infectious Diseases.

IDSA asked ABIM for several reforms, including a reduction in MOC fees, changes in the Longitudinal Knowledge Assessment questions (an alternative to the 10-year board exam), and eliminating redundant continuing medical education (CME) requirements.

In September, IDSA conducted a member survey about MOC requirements that garnered more than 800 responses. Overall, it revealed that the "majority of physician respondents reported the MOC program adds no clinical value, does not positively impact clinical practice, and contributes to burnout," Schmidt wrote.

In the survey responses, over 80% agreed with the following statements about MOC: "time required is a burden," "annual cost is a burden," and "points and assessment are a burden." Nearly 70% disagreed that MOC "positively impacts my clinical practice."

The IDSA's letter comes amid wider criticism of and pushback against MOC. Four cardiology societies announced in September that they planned to break away from ABIM and create a new, separate board for cardiovascular medicine.

Oncologists have also been questioning MOC, with the American Society of Clinical Oncology launching a member survey earlier this year to better understand their membership's feelings about certification. The American Society of Hematology also sent a letter to Baron, urging "immediate action" to establish a new and improved MOC program.

Baron announced earlier this year that he plans to retire in September 2024.

Critics have argued that there is limited evidence that MOC improves physician performance and patient outcomes. Previous MedPage Today reporting has shown that some specialty boards can be lucrative businesses, complete with highly paid executives and luxury trips.

Among IDSA's criticisms of the MOC program were its clinical relevance and the time and cost burden of the MOC exams and points system.

Infectious disease in particular has become increasingly more specialized, with a focus on certain diseases or populations, the letter stated. "Rather than issue a standardized, one-size-fits-all set of assessment questions and activities, it would be more relevant to allow physicians to be self-directed in their learning, requiring instead that they partake in a specific number of hours or credits in their medical educational training of choice," it said.

Cost, too, can be a problem, the letter noted. "ID physicians are among the lowest paid physicians in the United States, and the current MOC fees are cost-prohibitive for our members overall -- and particularly so for those early in their careers."

In general, to maintain board certification for internal medicine and infectious disease, physicians must take either a long assessment every 10 years, or a shorter test of 120 questions each year, and earn 100 MOC points every 5 years through CME activities, among others. These are requirements that can take anywhere from 25 to 62 hours per year, the letter stated.

In the specialty, physicians may have to maintain both internal medicine and infectious disease board certification, which can total as much as $4,100, according to the letter. Physicians are also responsible for costs associated with CME courses.

Though board certification is not always needed to practice, employment for many physicians is contingent on this credential, which many hospitals and insurers require.

Sophie Putka is an enterprise and investigative writer for MedPage Today. Her work has appeared in the Wall Street Journal, Discover, Business Insider, Inverse, Cannabis Wire, and more. She joined MedPage Today in August of 2021. Follow

Continue reading here:

Another Medical Society Turns Up the Heat on MOC - Medpage Today

Internal Medicine

Top docs of 2023and what it takes to be one – MD Linx

It takes grit and determination to become one of the best doctors in the US, as well as fierce dedication to compassionate patient care. Some common themes of being named the "best of the best" include taking advantage of opportunities, strong working relationships with nurses and other HCPs, speaking out for the safety of patients and staff, practicing self-care, and maintaining a knowledge base.[]

Here are some of the years best US physicians according to those who rank them, including what it takes to garner a coveted spot on a year-end, best-of list.

Castle Connolly

With more than 30 years in the game, Castle Connolly has raised the bar as a credible source of top doc data.[]

These doctors represent the top 7% of physicians in the country, as rated by their peers. Here are a few doctors who made the cut this year.

Dr. Manjeet S. Chawla, Chicago, IL, medical oncologist, Thorek Memorial Hospital, Saint Anthony Hospital, Chicago

Dr. Lucy M. McBride, Washington, DC, internal medicine, Foxhall Internists

Dr. Jeffrey R. Leonard, Columbus, OH, neurosurgeon, Nationwide Children's Hospital, The Ohio State University Wexner Medical Center

Dr. Holly Salzman, San Diego, CA, family medicine, UC San Diego Medical Center, Rady Children's Hospital

Castle Connolly collects data from the National Provider Identifier Registry (NPI), and collaborates directly with hospitals and physicians to come up with names for their Top Doctors list. The sites dedicated physician portal allows doctors to update their profile to have the best chance of being considered for the year-end list.

Top doctors are nominated by their peers and vetted by the Castle Connolly research team based on professional qualifications, hospital and faculty appointments, education, research leadership, professional reputation, interpersonal skills, disciplinary history, and outcomes data.

Castle Connollys focus on diversity

Castle Connolly recently debuted Top LGBTQ+ Doctors 2023, which recognizes exceptional physicians in the LGBTQ+ community who have exhibited outstanding expertise, patient care, and contributions in the field of medicine.

The 64 names on this list include physicians from 22 states across 34 specialties.[]

Being an LGBTQ+ physician adds a powerful dimension to their ability to serve patients because LGBTQ+ doctors embody visibility and representation, inspiring hope and confidence in their patients, says Alex Sheldon, Executive Director of GLMA (which partnered with Castle Connolly to produce the list). Having health professionals who understand the unique health needs of LGBTQ+ communities first hand is invaluable for fostering trust and achieving better health outcomes."

"Their visible presence challenges societal norms, breaks down barriers, and inspires future generations of LGBTQ+ physicians, creating a transformative ripple effect within the medical field."

Alex Sheldon, executive director of GLMA

The new distinction is part of Castle Connollys Diversity Equity and Inclusion (DEI) Initiative designed to celebrate physicians from diverse backgrounds and walks of life. To come up with the list of winners, Castle Connolly mined their current Top Doctors list. These doctors voluntarily shared information about their race/ethnicity, gender identity, and sexual orientation.

Other 2023 DEI initiatives include Top Black Doctors, Exceptional Women in Medicine, Top AAPI Doctors (Asian American and Pacific Islanders), and Top Hispanic/Latin Doctors.

The American Health Council

The American Health Council issues an annual Best in Medicine list of those who master the key roles that drive patient careadvocate, collaborator, communicator, decision maker, expert, manager, scholar.[]

The awards come in two flavors. First, the Leader in Medicine award is for physicians who have demonstrated exemplary conduct in their field and includes medical educators and clinicians who lead by example and inspire change.[]

The following are some Leader in Medicine winners:

James Kennedy, MD, MPH, FACEP, emergency physician, Quest Care/OU Medical Center

Dr. Keith A. Perry, medical director of Precision Pain Treatment Clinic in Smithfield, RI

Lawrence S. Miller, MD, Chief and Chairman of the Department of Orthopaedic Surgery at Cooper University Hospital and the Cooper Medical School of Rowan University

M. Scott Lucia, MD, associate professor and Chief of Genitourinary and Renal Pathology at the University of Colorado School of Medicine, Denver, CO

Here are some Award of Excellence winners:

Mohamad Jaafar, MD, professor and Chief of Ophthalmology, Childrens National Health System

Richard Nugent, MD, Clinician, CenseoHealth

Joshua Meyerson, MD, MPH, medical director, Health Department of NW Michigan

Nicholas Smyrnios, MD, ICU medical director, UMass Mememorial Medical Center

These physicians are recognized for their admirable character, selfless dedication, and outstanding effort. Perpetually raising the bar for all, they help establish a higher standard quality of care, per the American Health Council website.

What this means for you

To be honored as a top physician of the year is a remarkable achievement. Physicians who garner such accolades typically represent the full package: They not only help their patients but also their peers and community, leading by example with complete dedication to their craft.

Read the original here:

Top docs of 2023and what it takes to be one - MD Linx

Internal Medicine

SMH Addiction and Internal Medicine Clinic caring for the whole … – Sheridan Media

The Sheridan Memorial Hospital Addiction and Internal Medicine Clinic utilizes the use of medications, in combination with counseling and other therapeutic techniques, to provide a whole-patient approach to the treatment of substance use disorders.

Successfully treating addiction for 10 years, Dr. Jason Ackerman, MD is the leader of the team at SMH Addiction and Internal Medicine Clinic and is board certified in Addiction and Internal Medicines.

Dr. Ackerman told listeners of Sheridan Medias Public Pulse program what the team and many other professionals define as addiction.

Utilizing the Medication Assisted Treatment (MAT) approach to treating addiction in partnership with Northern Wyoming Mental Health allows the SMH Addiction and Internal Medicine Clinic to treat the patient physically and mentally, including primary care.

In 2021, Wyoming suffered 71 opioid overdose deaths, accounting for 65% of all drug overdose deaths in the Cowboy State. Treating the medical concerns or problems of patients with an opioid addiction means addressing issues and treatments differently than traditional medicine may prescribe. The team at the SMH Addiction and Internal Medicine Clinic takes these factors into account and treats patients accordingly.

According to Dr. Ackerman, with the advances in medicine and modern knowledge, addiction can be treated like the disease it is while the patient retains their dignity as they continue their journey to a better life.

No referral is needed to make an appointment with the SMH Addiction and Internal Medicine Clinic, call 307-675-2674, or visit the Outpatient Center at 1333 West 5th St. Suite 200 in

Sheridan.

707

Read more here:

SMH Addiction and Internal Medicine Clinic caring for the whole ... - Sheridan Media

Internal Medicine

Irene Chernova is the 2023 Dostanic Award Recipient – Yale School of Medicine

Irene Chernova, MD, PhD, instructor of medicine (nephrology) has been selected as the recipient of the 2023 Iva Dostanic, MD, PhD, Physician-Scientist Trainee Award.

The Dostanic Award is presented to a physician-scientist who exemplifies the qualities of the late Iva Dostanic, MD, PhD, a trainee who left a mark on the department.

Chernova is the thirteenth awardee, and was co-nominated by Joseph Craft, MD, Paul B. Beeson Professor of Medicine (Rheumatology) and professor of immunobiology and Stefan Somlo, MD, C. N. H. Long Professor of Medicine (Nephrology) and professor of genetics; chief, Section of Nephrology.

She came to Yale for residency training in 2015, after graduating from the University of Pennsylvania MD/PhD program. Chernova completed residency training and fellowship in the ABIM Physician-Scientist Research Pathway and joined the faculty in 2022. Her current research is focused on lupus nephritis and autoimmune inflammation of the kidney.

The kidney is a very unique, hostile microenvironment. Ive been seeking to understand how immune cells that hurt the kidney are able to survive, where they have no business being under healthy circumstances, and the implications this has for therapy for patients, said Chernova.

Chernova developed a new line of research in the Craft Laboratory, exploring the role of ions and Na+-K+-ATPase on B cell survival. She demonstrated that this ion pump is required for B cell survival during renal ionic stress, with lupus B cells resistant to such Na+ induced death. Their resistance promotes intrinsic kidney damage and subsequent progression of nephritis. This novel physiological finding also explained for the first time why B cell depletion, in addition to its effect on autoantibody reduction, is therapeutically successful in lupus nephritis, said Craft.

I feel humbled to be recognized by those I admire tremendously at my own institution, and to meet the criteria of the award and all that Iva embodied.

After giving birth to her first child in mid-April, Chernova is set to give the Dostanic Award Lecture at Medical Grand Rounds in June, several months into maternity leave. I cant think of a better reason to come in during my leave, exclaimed Chernova.

She first told her husband and a few friends about being selected for the Dostanic award. Next thing she knew, her husband started an email with family and friends with the subject line, Pregnant and killing it! and the congratulations began pouring in.

As an only child of an immigrant family, Dostanics story resonates with Chernova. Chernova draws parallels with her own upbringing, having moved to the U.S. at the age of 10. And like Dostanic, Chernova was also recruited to the ABIM Physician-Scientist Research Pathway.

To Chernova, the award means more than winning a national one. I feel humbled to be recognized by those I admire tremendously at my own institution, and to meet the criteria of the award and all that Iva embodied.

The history of the award dates back to 2011 when Iva Dostanic, MD, PhD, was recruited to the ABIM Physician-Scientist Research Pathway in the Department of Internal Medicine.

Iva was extremely productive as an outstanding graduate student, earning her PhD in molecular genetics, biochemistry, and microbiology at the University of Cincinnati. She was first author of five papers in the field of cardiovascular physiology that were very novel at the time. She could have immediately taken a faculty position in a basic science department, but she wanted to be a physician, as well as a scientist. So she decided to attend medical school at the Cleveland Clinic Lerner College of Medicine, said Peter Aronson, MD, C.N.H Long Professor of Medicine (nephrology), who was involved in her recruitment.

Iva was a candidate who epitomized the best of being a physician and scientist.

Aronson was the program director of the Physician-Scientist Research Pathway from 2006-2011, and during the interview process Dostanic made an impression as an extraordinarily outstanding candidate. In addition to her research accomplishments as a graduate student, Iva excelled in her clinical studies in medical school, receiving the student award for excellence in the art and practice of medicine. Iva was a candidate who epitomized the best of being a physician and scientist, Aronson added.

The day before graduating medical school, Dostanic received devastating newsshe had ovarian cancer.

When Dostanic came to New Haven a month later after major surgery and initiation of chemotherapy, leadership knew that the workload of residency training would be far too physically demanding. Dostanic delayed her training due to her health and instead began a research fellowship in the Section of Pulmonary, Critical Care and Sleep Medicine in the lab of Patty Lee, MD.

While undergoing chemotherapy, Dostanic continued to work in Lees lab.

Iva researched how lung cells respond to hypoxia and started to identify what the hypoxia-related signal transduction mechanisms were in lung vascular cells, with the ultimate goal of identifying novel therapies for pulmonary hypertension a deadly disease with no cures, said Lee.

As Dostanics health declined, she was hospitalized at Yale New Haven Hospital (YNHH). Faculty visited with Dostanic and her parents, and she radiated positivity even during the most challenging times of her illness.

Jack Elias, MD, the Department of Internal Medicine chair at the time, knew that something had to be done for Dostanic. Many thoughts ran through his head on how to honor her.

I sat up at night thinking and an idea came to me that we should have an award for the physician-scientist trainee. When I mentioned this, it resonated with everyone and we went ahead and created it. And Iva was the first recipient, said Elias, Dean Emeritus and Warren Alpert Foundation Professor of Translational Science, Professor of Molecular Biology, Cell Biology and Biochemistry, Professor of Medicine at Brown University.

In December 2011, Dostanic lost her battle to cancer at the age of 35. Before passing, Dostanic received what became known as the inaugural Iva Dostanic, MD, PhD, Physician-Scientist Trainee Award in a ceremony held in her hospital room at YNHH.

She was my role modeldespite all the challenges she faced in the final years of her life, she emanated strength, an unstoppable passion for science, and joyful spirit.

The following June, Patty Lee described Dostanics research in the first Dostanic Award Lecture that Lee presented on behalf of Dostanic.

She was my role modeldespite all the challenges she faced in the final years of her life, she emanated strength, an unstoppable passion for science, and joyful spirit, said Lee, Professor of Medicine in the Division of Pulmonary, Critical Care & Sleep Medicine at Icahn School of Medicine at Mount Sinai.

Science was easy for Dostanica way of life. Not only did she excel in it, she loved it. Dragana Dostanic, Ivas mother, likened the lab to her kingdom. She would tell us about the feeling of taking the elevator to the lab. You cannot imagine that feeling, shed say. Science and medicine was a world worth exploring. She found it endlessly intriguing as she loved solving puzzles. It was her joy, her love, and it wasnt hard for her to devote long hours to her research.

Dostanic is described as someone who would brighten any room and a full human being by Mark Siegel, MD, director of Department of Internal Medicines Traditional Residency Training Program.

Beyond her accomplishments, Dostanics parents detail how kind and humble she was. Although she would not describe herself that way, and she was not one to talk about her achievements. Iva was uniqueshe found beauty in everything and good in everyone. Every moment was a time for celebration, even from an early age.

Iva was uniqueshe found beauty in everything and good in everyone. Every moment was a time for celebration, even from an early age.

Each morning, Dostanic woke at 5 a.m and read scientific articles followed by going for a run. She loved restaurants, playing tennis and skiing, and also fashion. Dostanic was well dressed, put together and oftentimes sparked questions from others about where she was headed. Her response? Nowhere!

She spoke several languages and excelled at most things, but one thing she was not great at was singing. Dostanics parents recall laughing about how she could not carry a tune. That didnt stop her from singing though. When at the Cleveland Clinic she would enter the lab while belting out the national anthem, as she loved to make others laugh.

Iva had a great sense of humor. She took her work seriously, but not herself seriously, Dragana explained. A friend to all, Dostanic would uplift whoever she was around. Dragana describes how her daughter found beauty in each of her friends and that each person was a special gift to her.

And like most physician-scientists and scientists, Dostanic was concerned about funding. She was aware that her research depended on funding and always looked ahead to find new ideas for grants.

In 2015, Dostanics parentsDragana and Predrag Dostanicpledged their estate to Yale School of Medicine (YSM) to endow the Iva Dostanic, MD, PhD, Physician-Scientist Fund to support physician-scientist career development in her memory.

I think that she would fully approve that we support research and science. We strongly believe that she would want us to do what is important. The pain of losing her stays with us. You cannot beat the pain, you just learn how to live with it.

For them, it is a way to continue their daughters legacy.

Predrag explained, I think that she would fully approve that we support research and science. We strongly believe that she would want us to do what is important. The pain of losing her stays with us. You cannot beat the pain, you just learn how to live with it.

Sometimes I think she lived her life as if she was aware it would not be long. She was a fast burning star, Dragana shared.

Since over a dozen individuals have been selected for the honor, Dostanic and her story continue to have an impact.

The award in Ivas name has provided a small measure of consolation for all of us at Yale who knew her to find meaning in the devastating loss of this exceptional young woman, said Aronson.

Each December, the department announces a solicitation for nominations with a deadline for submission at the end of January or beginning of February. A physician-scientist is selected by a committee shortly thereafter, and the recipient receives the award and presents the award lecture on a research topic of their choice at Medical Grand Rounds (MGR) in June. The awardee is also recognized at a dinner the preceding evening.

Prior to the pandemic, the Dostanics would visit New Haven for the awardees MGR each June. This June will be the first year the Dostanics are joining in person since 2019. I see Iva in each and every one of the recipients. I see this spark, this intelligence, this enthusiasm, I see her. I see her and I'm so happy to see that, said Dragana.

Winning the award was a really nice opportunity to meet the Dostanic family, as they believe in the physician-scientist training modality.

Aspiring physician-scientists should know that being a physician-scientist is truly a labor of love. There are many, many challenges inherent to this career decision, said Daniel Jane-wit MD/PhD.

Iva Dostanic was such a talented and dedicated physician scientist that to be recognized with her award was very humbling and an honor. Out of the awards I've received, this one is the most meaningful to me because when I've had challenges in my career, I think of the challenges that Iva had and how her resilience and hard work never stopped her from accomplishing her goals. She was a true role model for early career investigators. She was certainly a role model to me.

Discipline determines destiny, not desire. To achieve your goals, you have to put your head down and do the work to forge your future rather than waiting for people to give you what you desire without actually putting in the work, said Jose Herazo-Maya, MD.

"Iva left an incredible legacy at YSM, as well as in my own section, and I was (and still am) deeply honored to have received an award in her name. It is an incredible honor to be recognized by one's own institution and colleagues, and this award was even more meaningful in light of Iva's legacy. The award gave me the chance to get to know Iva's wonderful parents, who I still look forward to seeing at the reception every year. The award also afforded me the opportunity to present at MGR, even though I had only joined the faculty the year prior, which was a wonderful opportunity to share my research with the department, said Lauren Ferrante, MD, MHS.

I wish I had the privilege of knowing Iva. I only learned about her inspiring life when I received this award. She was a young woman who had a genuine passion for science, for the scientific process. She loved the pursuit of scientific discovery and kept going despite the obstacles life threw her way. I was humbled and honored when I received the award. The award plaque is proudly displayed on my bookshelf in my office at work. Even though its been five years since I took this position at UT Southwestern, I have still yet to hang any of my other awards or diplomas in my office, or pictures for that matter. So the Dostanic Award plaque is a primary source of inspiration and constant reminder of Ivas spirit and perseverance.

Becoming an independent investigator and learning how to build and run a laboratory has been challenging, but also rewarding. Any time Im stressed about something or dealing with a challenge that at the time seems insurmountable, her memory gives me pause and the motivation to press on. I hope to honor Ivas memory by being a role model for future scientists by empowering young trainees and instilling a passion for science, said Sarah Huen, MD, PhD.

I never met Iva, but from what I learned about her, she was extremely driven, talented, focused, and a tremendous force for good. So, it means a lot to me to be associated with such a person. When I got the award, I had a chance to spend some time with her parentsgetting to know them, learning about Ivas life, and presenting my work at MGR. I think its motivated methinking about the many things she accomplished, and her tireless approach and work ethicit definitely helps me to push on when I face challenges, said Stephen Baldassarri, MD, MHS.

This award has been an incredible honor. Iva was the consummate physician-scientist, and her passion for research has continued to inspire me over the years. I feel privileged to be associated with her and the qualities she embraced, and thank Dragana and Predrag Dostanic for their generous contribution to the development of physician-scientists at Yale.

I would encourage trainees to find joy in their work, to persevere, and to embrace their individual journey through academic medicine, said Rupak Datta, MD/PhD, MPH.

Receiving this award in Iva Dostanics memory has meant so much to me. I am incredibly grateful, and it is truly one of my proudest achievements as a physician-scientist. This award has had a significant impact on my career development. The opportunity to present at MGR allowed me to share my work with a broad audience across the Department of Internal Medicine. It has also facilitated my ability to apply for career development awards. The values that Iva Dostanic embodied as a physician-scientist and her excitement, focus, and dedication inspire me. They are a reminder of why I do what I do daily, the love for science and passion for caring for and improving the lives of my patients.

Ivas story is so moving and inspirational. I am amazed by the impact that she has had on so many, including myself. It was such an honor to receive the award in her memory. I hope to pay tribute to her through my dedication to pursue translational research that can one day impact patient care. I also hope to always approach my research and patient care with the passion and joy that Iva Dostanic exemplified.

I would encourage other aspiring physician-scientists to surround themselves with strong mentors early in their careers. For me, this has included a multidisciplinary team of scientific advisors as well as mentors who have really supported me and guided me in my career development. The path of a physician scientist can be challenging at times, with various transitions, and having a good support system can make all the difference, said Ana Luisa Perdigoto, MD, PhD.

Iva was a force of nature; she persevered even when everything seemed to be falling apart. Her spirit of perseverance despite the odds is what I admire most. This award was not only an honor that helped me feel supported by the department, but also helped crystallize my thoughts regarding the potential of my work so that I can further hone my ideas and research direction. In the beginning of my career, it is easy to get excited about many different ideas, but the MGR was helpful in focusing my ideas and getting feedback so that I can identify areas where there may be more excitement that I could then capitalize upon. This award gave me encouragement to continue persevering in the pursuit of my research question.

Mentorship teams are key to navigating the ups and downs of an academic research career. We all stand on the shoulders of giants, who can show us the right directions to look, said Dennis Shung, MD, MHS, PhD.

As an intern at Yale, I remember sitting in the grand rounds where the Dostanic award was presented and being so inspired by Ivas story. Through residency and fellowship, I often thought of Ivas passion and her legacy. It was such an honor to have received this award and be recognized by ones own mentors and institution. This award has inspired me to promote the physician-scientist career and help junior trainees navigate this exciting, yet uncertain path, said Benjamin Goldman-Israelow, MD/PhD.

2012Iva Dostanic, MD, PhD, Pulmonary, Emerging Roles for Innate Immunity in Lung and Endothelium (presented by Patty Lee, MD)

2013Isaac Hall, MD, MS, Nephrology, Donor Kidney Quality and Acute Kidney Injury with Transplantation

2014Daniel Jane-wit, MD/PhD, Cardiology, "Translational Approaches for Studying Cardiac Allograft Vasculopathy"

2015Jose Herazo-Maya, MD, Pulmonary, Predicting Outcome in IPF: The Dawn of Genomic Biomarkers

2016Lauren Ferrante, MD, MHS, Pulmonary, Improving Post-ICU Outcomes: A Call to Action

2017Sarah Huen, MD, PhD, Nephrology, Acute Kidney Injury: Not All That is Inflammatory is Pathologic"

2018Stephen Baldassarri, MD, MHS, Pulmonary, Electronic Cigarettes: The End of Smoking or a Deadly New Addiction?

2019Shelli Farhadian, MD, PhD, Infectious Diseases, Neuroinflammation During Chronic HIV Infection

2020Rupak Datta, MD/PhD, MPH, Infectious Diseases, Antibiotic Stewardship to Promote Palliative Care in Older Adults Near the End of Life

2021Ana Luisa Perdigoto, MD, PhD, Endocrinology, Clinical and Preclinical Insights into the Mechanisms of Checkpoint Inhibitor-induced Diabetes

2022Benjamin Goldman-Israelow, MD/PhD, Infectious Diseases, Prime and Spike: A Novel Vaccination Strategy for Inducing Mucosal SARS-CoV-2 Immunity

2022Dennis Shung, MD, MHS, PhD, Digestive Diseases, Human+AI in Medicine

The Department of Internal Medicine at Yale is among the nation's premier departments, bringing together an elite cadre of clinicians, investigators, educators, and staff in one of the world's top medical schools. To learn more, visit Internal Medicine.

See the rest here:

Irene Chernova is the 2023 Dostanic Award Recipient - Yale School of Medicine

Internal Medicine

Sanders, HBCU medical schools in Atlanta to talk health care diversity – The Atlanta Journal Constitution

The HBCU medical school leaders suggested enhancing infrastructure, supporting clinical research opportunities for HBCUs, investing in mental and behavioral health practitioners and funding additional residency and fellowships opportunities for aspiring doctors, as ways to increase the number of Black doctors in the health care workforce.

Were going to do our best to grow the health care workforce, Sanders said. Were putting special focus on the need for more Black doctors, nurses, psychologists, dentists.

The roundtable was the first field event that Sanders has held as HELP Committee chairman, a role that he assumed in January.

Later during the program, current Morehouse medical students spoke about the challenges they have faced as Black medical students. One of challenges discussed was amount of debt that comes with pursuing a career as a doctor.

The greatest barrier to entry for burgeoning Black physicians is the immense and seemingly insurmountable financial risk weighted to shackle all those who pass through the gates of medical education, Dr. Samuel Cook, an internal medicine resident physician at Morehouse School of Medicine, said.

According to leaders, HBCU medical schools do not have the same financial resources and endowments of other medical schools.

Our mission to train culturally competent providers willing and eager to serve their community comes at a cost, Montgomery Rice said.

Both leaders and students advocated for loan forgiveness for doctors committed to serving in underserved communities. They also emphasized the need for pipeline programs for the medical field and other science, technology, engineering and math fields for youth in communities of color.

I am very pleased that Senator Sanders and the HELP Committee are appreciating the need to step outside of Washington D.C. and actually hear the community, Montgomery Rice said. Im equally happy that we were able to share with them some solutions.

The Atlanta Journal-Constitution and Report for America are partnering to add more journalists to cover topics important to our community. Please help us fund this important work at ajc.com/give

More here:

Sanders, HBCU medical schools in Atlanta to talk health care diversity - The Atlanta Journal Constitution

Internal Medicine

Capital Area Health Consortium Honors UConn Health Nurse … – University of Connecticut

The Capital Area Health Consortium, the group of Connecticut hospitals that employs medical residents and fellows in UConn-sponsored programs, announces honors for one fellow, one resident, and one nurse.

The consortium presented its Community Service Awards to Dr. Jasmin Hundal, an internal medicine fellow, and Dr. Joselyn Miller, an emergency medicine resident, and its T. Stewart Hamilton, MD, Fellowship Scholarship to Elizabeth Haskell, a quality assurance specialist.

Hundal is a graduate of UConns internal medicine residency and is the first to be accepted into the internal medicine fellowship program.

Dr. Hundal embodies the leadership our community expects from physicians, according to her nomination, submitted by Dr. Robert Nardino and Dr. Jacyln Cox, who lead the internal medicine residency program. She serves as a role model for young physicians and medical students. She goes above and beyond to bring together residents and students from different backgrounds to share a common cause of serving our community at a time when it is needed more than ever.

Her nominators say Hundal has demonstrated leadership in health equity throughout her residency and fellowship, citing examples including educating peers about disparities in medicine, organizing a Grand Rounds on responding to patient bias, and leading efforts to assist the homeless and those struggling with poverty or hunger.

Receiving this award is an honor that deeply resonates with my commitment to our community, both inside our hospital and out in the wider world, Hundal says. This recognition underscores the importance of our work in the health equity track, which Ive been privileged to steer. I express my profound gratitude to my mentors: Drs. [Kirsten] Ek, [Christopher] Steele, [Robert] Nardino, [Steven] Angus, and [Eric] Mortensen. Their guidance and support from the onset have been fundamental to my growth and achievements. This award not only validates our collective efforts but also renews my dedication to advancing health equity, making a meaningful difference in the lives we touch.

Miller is credited with sharing her perspective as a Black female physician and mentoring the next generation of residents.

She has visited local magnet schools to help provide guidance to underrepresented students starting their journey towards becoming medical professionals, Dr. Shawn London and Dr. Cynthia Price, who lead the emergency medicine residency program, write in their nomination. She is a kindhearted and thoughtful individual who has, in addition to her volunteer efforts in the greater Hartford area and in the medical student realm, dedicated a large amount of additional effort as co-chair of the UConn Resident and Fellows Forum in the 2022-23 academic year,

Her examples of community service include organizing an event for residents and fellows to create toys and blankets for the Animal Foundation, volunteering as a medical support physician at the Connecticut SWAT Challenge, and volunteering on the panel for the America Medical Womens Association to help female students strategize their career goals.

Haskell is applying the scholarship to her study in UConns Adult-Gerontology Acute Care Nurse Practitioner Program, which she started in the fall. Shes been a UConn Health nurse for the last seven years, during which time shes worked in the emergency department, intensive care unit, and cardiac catheterization lab before moving into her quality assurance role, which focuses on sepsis prevention.

Liz maintains a strong clinicians perspective, demonstrated by her ongoing review of evidenced based practice related to sepsis, as well as her continual study of sepsis related core measures, writes her nominator, Michelle DeLayo, director of critical care, advanced practice staff, and patient quality and safety. The SEP1 core measure is challenging and complex, but Liz collaborates closely with our core measure quality assurance nurse to audit patients in the institution in real-time to improve compliance with the metrics. Liz has developed a process to identify and follow patients that present with potential and actual sepsis and works directly with the care teams from admission to discharge to ensure the patients are provided optimal care.

DeLayo also credits Haskell with being among the first to volunteer to assist with the surge of patients during the COVID pandemic, offering to take additional shifts, and providing critical care education to those who were helping in the ICU.

I am honored to be a recipient of the T. Stuart Hamilton, MD, Fellowship Scholarship, Haskell says. It means a lot to me to be supported as I pursue an advanced degree and overcome the barriers of being a working mother and first-generation college graduate. I hope to inspire others to do the same.

The six-hospital Capital Area Health Consortium administers the salary and benefits to all the residency and fellowship programs the UConn School of Medicine sponsors. It also provides educational seminars to residents and fellows to help them plan life after residency.

The member hospitals include UConn John Dempsey Hospital, Connecticut Childrens, Hartford Hospital, the Hospital of Central Connecticut, the Hospital for Special Care, and Saint Francis Hospital and Medical Center.

Go here to see the original:

Capital Area Health Consortium Honors UConn Health Nurse ... - University of Connecticut

Internal Medicine

Alzheimer’s treatment Leqembi could cost Medicare up to $5 billion per year, study estimates – CNBC

The Alzheimer's drug Leqembi is seen in this undated handout image obtained by Reuters on Jan. 20, 2023.

Eisai | Reuters

The new Alzheimer's antibody treatment Leqembi could cost Medicare up to $5 billion per year, according to research published in a leading medical journal this week.

Medicare would spend about $2 billion per year if around 85,700 patients test positive for the disease and are treated with the Eisai and Biogen product Leqembi, according to the research published Thursday in JAMA Internal Medicine.

The program for seniors would spend $5 billion if around 216,500 patients become eligible for the breakthrough treatment, according to the study.

The authors said the estimated costs to Medicare are conservative and that spending on Leqembi might increase more than anticipated depending on demand and other factors.

The researchers who conducted the JAMA study included physicians and public health and policy experts. They are affiliated with the University of California Los Angeles, the Rand Corporation, Harvard Medical School and Beth Israel Deaconess Medical Center in Boston, among other institutions.

Eisai and Biogen have priced the twice-monthly antibody infusions at $26,500 per year.

There are also additional annual costs estimated at $7,300 per patient associated with neurologist visits, MRI tests and PET scans, administration of infusions, and monitoring for and treatment of potential side effects, according to the researchers.

The study assumed Medicare would cover 80% of the costs, with patients left to pay the remaining 20% in full or in part depending on whether they have supplemental insurance.

Patients could face an annual bill of about $6,600 per year depending on the state they live in and whether they have supplemental insurance, according to the study. Some lower-income people who qualify for Medicare and Medicaid would pay nothing out of pocket.

Read CNBC's latest global health coverage:

The Alzheimer's Association, which lobbies on behalf of patients living with the disease, estimates Alzheimer's and other forms of dementia will cost the U.S. $345 billion this year. Those costs could rise to $1 trillion by 2050, according to the association.

"That's the case without treatment. Prevention and treatment is the only path toward reducing this cost over time," Robert Egge, the association's head of public policy, said in a statement.

"But it's not cost that should determine if people have access to life improving care it's about the impact on people," Egge said. "Treatments taken in the early stages of Alzheimer's could mean a better quality of life."

Leqembi had a positive effect on patients with early Alzheimer's disease in clinical trial results published in the New England Journal of Medicine in January.

The expensive treatment is not available to the overwhelming majority of patients right now because Medicare has severely restricted coverage of the antibody.

Medicare has promised to provide broader coverage of Leqembi if the FDA grants full approval of the treatment in July. Leqembi received expedited approval from the Food and Drug Administration in January.

The Alzheimer's Association, members of Congress and state attorneys general are pushing for Medicare to drop its restrictions and fully cover Leqembi.

The antibody treatment, which targets brain plaque associated with the disease, slowed cognitive decline by 27% in Eisai's clinical trial.

There are currently no other drugs on the market that have demonstrated this level of efficacy at slowing Alzheimer's disease. Eli Lilly's donanemab demonstrated promising clinical trial results earlier this month. The company plans to apply for full FDA approval this quarter.

Leqembi and donanemab both carry serious risks of brain swelling and bleeding.

View post:

Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates - CNBC

Internal Medicine

The COVID ’emergency’ is over. Should I relax precautions or still … – NPR

A poster in Kolkata, India, from peak pandemic days sends a message to mask up. Now that the official COVID-19 global emergency is no longer in effect, some folks are thrilled to stop masking but others wonder if it's a good idea to keep up certain precautions. NurPhoto via Getty Images hide caption

Last Friday, the World Health Organization ended the Public Health Emergency of International Concern that it announced three years ago when the virus that causes COVID-19 became a global threat. And the Centers for Disease Control and Prevention ended its public health emergency, effective May 11.

The FAQ series published in the Goats and Soda blog was a cornerstone of NPR pandemic coverage, touching on everything from transmission via pets (possible but unlikely) to whether a glass of wine after a vaccine is advisable (seems ok). As the world enters a new phase of the pandemic, we talked to public health gurus about how to move forward since the disease appears to be here to stay even as the emergency is lifted. Dear readers, if you have questions about this new phase of the pandemic, write us at goatsandsoda@npr.org and put "FAQ" in the subject line. Please include your name and location. We'll be answering a sampling of questions in a follow-up FAQ.

So remind me, what was the purpose of the emergency state?

Thomas Bollyky, senior fellow for global health, economics and development at the Council on Foreign Relations, says that a public health emergency is "really designed to spur international cooperation around a public health event that is serious, sudden, unexpected and requires immediate attention."

And what makes this an appropriate time to end the emergency state?

Last week when the World Health Organization ended its 3-plus year Public Health Emergency of International Concern, the emergency committee advising the WHO's Director General said it was time to do so because of "the decreasing trend in COVID-19 deaths, the decline in COVID-19 related hospitalizations and intensive care unit admissions, and the high levels of population immunity to SARS-CoV-2 [the virus that causes COVID-19]."

In the U.S., the Centers for Disease Control and Prevention said the U.S. Public Health Emergency was ending because "as a nation, we now find ourselves at a different point in the pandemic with more tools and resources than ever before to better protect ourselves and our communities."

Did those agencies do a good job explaining themselves?

Well, the quotes from the CDC and WHO are clear.

But Bollyky says articulating the targets and goals for the ending the pandemic all along such as how low the case and death counts would need to be to lift mask mandates or school closures would have helped the public understand why the agencies felt that May 2023 was the right time to conclude the public health emergency. "If the public can't see progress, it will be harder to convince them next time that these emergency measures are necessary," says Bollyky.

And how big of a threat is COVID now?

The announcement that the emergency is over doesn't mean the virus been vanquished, says Dr. Wafa El-Sadr, director of the Global Health Initiative at the Mailman School of Public Health at Columbia University. It's still infecting thousands and killing thousands each week.

Then again, so are diseases like malaria and cholera.

And just as we take those diseases seriously, we should take COVID-19 seriously, say the experts.

"HIV doesn't have a public health emergency declaration, tetanus doesn't have a public health emergency declaration, and yet people stay up to date with vaccinations and treatments," says Dr. Amesh Adalja, senior scholar at the Johns Hopkins Center for Health Security, "People don't need a public health emergency to take something seriously."

Nonetheless, the reassuring message from CDC and WHO is that you're less likely to catch COVID-19 because case counts have dropped due to vigilance and treatments.

"WHO now sees COVID-19 as a threat in our regular repertoire of things-trying-to-kill-us," says epidemiologist Katelyn Jetelina. a health policy epidemiologist with the Meadows Mental Health Policy Institute in Dallas, who writes the blog Your Local Epidemiologist. And the truth is that the world now has better tools and treatments for COVID than for some age-old diseases: from the readily available self-tests to vaccines and boosters to the paxlovid pill to lessen severity for higher-risk patients.

So is it ok to just blithely dismiss a case of COVID?

Even if you're an individual with no health risks and you catch the virus, there are things to worry about: just plain feeling awful is possible even if you're not high-risk. You might have to miss work. You run a risk of long COVID. And then there's the possibility you could transmit the virus to others at risk of severe COVID and death from the virus.

And what if you test positive and have risks: say, you're older, immunocompromised or have underlying health conditions such as obesity, heart disease, a compromised immune system or diabetes. Don't just figure you can beat it on your own. Reach out to your doctor right away, says Dr. Aaron Glatt, chair of medicine at Mount Sinai South Nassau in Oceanside, N.Y. "There are effective treatments available for high-risk infected individuals that are underutilized. You may be a candidate, which could reduce your possibility of progressing to severe disease."

For example, there's the COVID antiviral drug paxlovid which has been proven to help. A review of federal data in JAMA Internal Medicine found that the risk of long-term health problems, hospitalization and death after a COVID-19 infection diminishes among those who take the medication within five days after testing positive. That's according to an analysis of federal health data by researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care system.

So then ... is it wise to keep maybe some precautions?

Many physicians interviewed for this story tell us they still take precautions they think warranted. "Professionally, I still wear a mask for most patient care in the clinic and the hospital," says Dr. Luis Ostrosky-Zeichner, chief epidemiology officer at the Memorial Hermann Healthcare System in Dallas.

"In my personal life," he adds, "I still have A Purell dispenser in my car and carry a small bottle when I travel. I wear a mask in the airport and until the plane takes off since I'm less exposed in my own seat and [because of] the plane's ventilation system and then put it on again and wear it until I get to my hotel room. And yes, I still have tests at home and travel with a pair of them."

And while many many people are glad to doff masks forever and plunge back into the madding crowds in transportation hubs, concert arena and sports venues, others are understandably ... nervous.

If you don't have underlying conditions that put you at risk and feel uncertain about how to proceed, have an honest converation with your doctor or health-care provider, suggests Dr. Preeti Malani, a professor of medicine in the Divisions of Infectious Diseases and Geriatric Medicine at the University of Michigan. Ask how to gauge your personal risk.

Malani does believe that too much worry is not good for you: Fear of COVID or severe anxiety out of proportion to risk can lead to depression and other mental health concerns, says Malani.

So she's a champion of being realistic rather than fatalistic.

"We have the tools to mitigate and manage risk so that we can do all the things that are important to us," says Malani. She notes that people should keep in mind that masks work well especially when they are worn, if needed, and you are fully vaccinated. And it may be reassuring to have a plan for testing and treatment if needed.

So the idea is, to mask or not to mask ... it's up to me?

You are the keeper of your own health and the best authority on your own risk factor.

It is worth noting that even though masks were often deemed ineffective in the U.S. in the early days of the pandemic, global evidence shows that N-95s and KN-95s worn properly do reduce your risk of contracting COVID (not to mention the flu and other respiratory ailments). And the U.S. did eventually embrace masks.

You may still need to mask up in certain places, like health-care faciliites although rules are changing, with many hospitals and doctors offices ending the requirement for staff and patients. But that doesn't mean you have to take yours off. And if you're concerned you can ask maskless staff that interact with you to put one on. (And if you see a carelessly worn mask, you can muster up your best public-health voice and remark a mask should go above the nose.)

And ... keep getting those boosters, right? Or maybe not so necessary if it's not an emergency?

The rapid development of effective COVID vaccines around the world has been a medical marvel. There will be periodic new boosters available. But don't necessarily expect to be prodded on your cellphone one NPR reporter just got a message that his vaccine reminders will cease.

So with the emergency state over, you may have to pay attention to your own vaccine schedule rather than hearing calls from the government to go get your booster.

And public health specialists note that you shouldn't just focus on COVID when it comes to vaccines. "Learn about and stay up to date on all vaccines," says Dr. William Schaffner, medical director of the National Foundation for Infectious Diseases. The first-ever vaccine for adults to prevent respiratory syncytial virus (RSV) is expected to be available by September in the U.S.. Then there are easonal flu shots and likely a new COVID booster. "Adults will want to talk to their doctors this fall about all the vaccines they need," he says.

Are there any surprising lessons from this emergency?

Loneliness sucks more than you can imagine. Yeah, well maybe that's not a big surprise but the pandemic reinforced the toll that a lack of social contacts can take on mental health.

Dr. Malani is the lead researcher on a January 2023 survey of more than 2,500 people ages 50 to 80 conducted by the University of Michigan Institute for Healthcare Policy and Innovation and supported by AARP and Michigan Medicine. The survey found that one in three people between the ages of 50 and 80 say they sometimes or often experience loneliness.

That's down from about half of older adults in June 2020, when remaining at home was advocated in order to help prevent contracting COVID-19. But it's still noteworthy, says Malani: "If anything, the pandemic has shown us just how important social interaction is for overall mental and physical health and how much more attention we need to pay to this from a clinical, policy and personal perspective."

She says that even for people at risk of severe disease from COVID-19 there are precautions to take to help avoid isolation including online conversations, meeting outdoors where risk of transmission is lower, continued masking and especially talking to your doctor to get a clear sense of your risk of severe disease.

"Some people who were treated for cancer years ago continue to worry that they are at high risk," says Malani. "A talk with your doctor can help you determine risk and precautions to help you engage with people and activities you enjoy." On a personal note, she says she masks when caring for patients but otherwise generally does not mask in meetings or even while traveling these days. "I pay attention to how I feel and am careful about not exposing anyone if I have any symptoms at all, even if mild," she says.

And when should I test for COVID in this post-emergency era?

Consider testing if you have been exposed to someone with the virus or have symptoms that could be COVID-19, especially if you fall into a high risk group, say the doctors we interviewed. And hang onto those masks. You'll want one if someone in your home tests positive so you can protect yourself and protect others if you test positive.

So can you sum it all up for me?

The end of the national emergency around COVID-19 means that there will be certain bureaucratic changes in the way COVID is handled, says Dr. Leana Wen, an emergency physician and professor of health policy and management at George Washington University. For example, she says, there will be less collection and posting of COVID data and fewer requirements for local public health departments to check in with the CDC.

But we're going to be living with COVID-19 for ... a while. Wen, who gave birth to her second child during the pandemic, says "it has become clear that this coronavirus will be with us for the foreseeable future and is an infectious disease that must be prevented, treated, and managed, like other serious conditions. The focus should shift from population-wide measures to safeguarding the most vulnerable and investing in better vaccines and treatments to help those at highest risk from severe outcomes due to COVID-19."

Editor's note: To all the medical professionals who have kindly shared their time and insights to answer questions for the coronavirus FAQ series even as many of them put themselves at risk of infection while caring for patients we offer our heartfelt gratitude.

Read this article:

The COVID 'emergency' is over. Should I relax precautions or still ... - NPR

Internal Medicine

Liu Wins ASCI Emerging-Generation Award < Internal Medicine – Yale School of Medicine

Elise Liu, MD, PhD, associate research scientist in medicine (immunology) and instructor in medicine (rheumatology), was selected for an American Society for Clinical Investigation (ASCI) 2023 Emerging-Generation Award. One of 25 recipients to receive the honor, Liu was recognized at the AAP/ASCI/APSA Joint Meeting on April 22.

The award offers post-MD, pre-faculty appointment physician-scientists access to the Joint Meeting and two years of programming, with the intent of providing peer support and inspiration to help recipients stay on the path to becoming physician-scientist faculty.

It's wonderful to be recognized at this early stage in my career, Liu said. And its wonderful to have the opportunity to connect with a cohort of awardees who are in the same boatwere all trying to obtain funding and advance our careers.

Lius research focuses on the mechanisms of food allergy. She became interested in the subject when her first child, age one at the time, broke out with hives and vomited after eating peanuts. Liu was a student at Yale School of Medicine (YSM) at the time. It was scary for a parent, as you can imagine, she said.

Its wonderful to have the opportunity to connect with a cohort of awardees who are in the same boatwere all trying to obtain funding and advance our careers.

The incident led Liu to meet with allergists and learn all she could. I was surprisedand maybe disappointedto find out that we dont know much about why allergies develop and that there are limited options for treatment, she said.

After earning her MD, Liu joined the lab of Stephanie Eisenbarth, MD, PhD, associate professor adjunct, to study immunology research in food allergy, as part of the Investigative Medicine Program, which provides individualized research training for physicians that leads to a PhD degree. Under the mentorship of Eisenbarth, Liu examined the role of the antibody immunoglobulin A (IgA) in food allergy, collaborating with researchers across the country to gather patient samples.

While Liu found that IgA does not play a protective role against food allergy, she continues to examine the antibodys role in oral immunotherapy, in which small amounts of an allergen are fed to patients to build their tolerance of the food. Ultimately, Liu hopes to start her own research program.

The ASCI Emerging-Generation Award definitely motivates me to go after the goal of becoming an independent physician-scientist, she said.

The Section of Rheumatology, Allergy and Immunology is dedicated to providing care for patients with rheumatic, allergic, and immunologic disorders; educating future generations of thought leaders in the field; and conducting research into fundamental questions of autoimmunity and immunology. To learn more about their work, visit Rheumatology, Allergy & Immunology.

Visit link:

Liu Wins ASCI Emerging-Generation Award < Internal Medicine - Yale School of Medicine

Internal Medicine

QC Kinetix (Summerville) Offers a Variety of Regenerative Medicine Therapies in Summerville, SC – Yahoo Finance

Summerville, SC - (NewMediaWire) - May 12, 2023 - QC Kinetix (Summerville) offers treatment interventions for chronic pain, hair loss, and musculoskeletal conditions. The biologic therapies log into the body's self-healing mechanisms to hasten recovery. When patients first arrive for a zero-obligation consultation, they are ushered into a modern treatment facility to discuss their condition and the ways regenerative treatment can help them. The medical providers at the QC Kinetix (Summerville) pain control clinic have extensive experience working with patients taken aback by shoulder pain, hip pain, wrist pain, joint pain, lower back pain, and pain due to arthritis, among other conditions.

The well-researched and clinically tested treatments administered at QC Kinetix (Summerville) are a product of medical providers who understand pain in all its facets. Their hair restoration treatment is designed to help with hair growth and is only available in a few clinics. The providers at the clinic are conversant with the top-level- care concept when providing regenerative medicine therapies. Once the patient's condition is examined and determined, the medical providers will develop a customized treatment plan that meets the patient's medical needs. The selected therapies aim to achieve the set treatment goals, which include easing pain once and for all.

The team of providers at QC Kinetix (Summerville) includes Michael Garzone, FACP, FHM, DO; Alexandra White, PA-C; and Marc Difronzo, PA-C, MMS. Garzone studied Internal Medicine at Lake Erie College of Osteopathic Medicine and has extensive experience in palliative care, hospitalist medicine, critical care medicine, and geriatrics. Long Island native Marc Difronzo holds a B.S. in Exercise Science and has served in the military as a Special Operations for 16 years. He has also had six deployments with South Carolina Army National Guard. Board-certified physician White has interests in movement and exercise and regenerative medicine.

The QC Kinetix (Summerville) pain control clinic has become a center of interest for patients seeking natural hair regrowth treatments. The hair loss treatment Summerville is ideal for clients frustrated with hair loss. During the consultation, the team will explain to the patient the different treatments and explore the most plausible strategies to regain hair follicles. The clinic's tailored hair loss treatment Summerville regimen is multifaceted and several before and after images of patients undergoing treatments have been published on the website to give patients a sneak peek of the protocol's restorative ability. The results of the treatment intervention will vary from one patient to the other depending on the underlying condition.

A tear or strain in the ankle can cause stinging pain in the area where the subtalar, talocrural, and inferior tibiofibular join together to facilitate motion. Before treatment, QC Kinetix (Summerville) doctors will look out for symptoms like bruising, swelling, and skin discoloration and perform physical examinations. Once the diagnosis is issued, the medical providers will administer regenerative therapies to neutralize pain and inflammation. A patient who has been reeling from ankle pain said, "I've been with these great people for about 2 years now and when I started I was having pain from my ankles to my hips and when I say it helps it really does it's so amazing how these injections gave me so much relief."

QC Kinetix (Summerville) medical providers have put their in-depth experience to practice by providing cost-effective regenerative therapies. The team can be contacted at (843) 303-9825. They operate from an advanced treatment facility located at 1565 Rose Dr Unit B, Summerville, SC, 29483. Additional resources are provided for medics and investors looking to invest in the QC Kinetic franchise.

Media Contact:

Company Name: QC Kinetix (Summerville)

Contact Person: Marc Difronzo

Phone: (843) 303-9825

Address: 1565 Rose Dr Unit B

City: Summerville

State: SC

Postal Code: 29483

Country: USA

Website: https://qckinetix.com/charleston/summerville-sc/

Here is the original post:

QC Kinetix (Summerville) Offers a Variety of Regenerative Medicine Therapies in Summerville, SC - Yahoo Finance